Log In
Print
BCIQ
Print
Print this Print this
 

Sustol (APF530)

  Manage Alerts
Collapse Summary General Information
Company Heron Therapeutics Inc.
DescriptionLong-acting formulation of granisetron, a serotonin (5-HT3) receptor antagonist, formulated using Biochronomer drug delivery technology
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationEmesis
Indication DetailsPrevent acute and delayed chemotherapy-induced nausea and vomiting (CINV); Prevent delayed-onset chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy
Regulatory Designation

U.S. - Undisclosed Review (Prevent acute and delayed chemotherapy-induced nausea and vomiting (CINV))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today